ARPHA OAI-PMH Endpoint
metadata only
Improving pharmacoeconomic evidence of therapeutic drug monitoring for chronic inflammatory diseases across Europe
This manuscript aims to present the authors’ position on the current evidence and identify key gaps in the pharmacoeconomic evaluation of therapeutic drug monitoring (TDM) for chronic inflammatory diseases (CIDs) across Europe. Specifically, it will address: (i) the clinical effectiveness and safety
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- WHO Regional Office for Europe Antimicrobial Medicines Consumption (AMC) Network: AMC data 2020–2021#470954
- Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics#827190
- Editorial: Challenges of Pharmacoeconomics in Global Health Arena#384152
- Toward Efficient Estimation of Regional Treatment Effects in Multi-Regional Clinical Trials#616616
- Toward Efficient Estimation of Regional Treatment Effects in Multi-Regional Clinical Trials#616116
Record · ID 1473488
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive